1. Cuckle HS, Wald NJ, Thompson SG. Estimating a woman’s risk of having a pregnancy associated with Down’s syndrome using her age and serum fetoprotein level. Br J Obstet Gynaecol 1987; 94: 387-402.
2. Arbuzova S, Cuckle H, Mueller R, Sehmi I. Familial Down syndrome: evidence supporting cytoplasmic inheritance. Clin Genet 2001; 60: 456-462.
3. Schupf N, Kapell D, Lee JH, Ottman R, Mayeux R. Increased risk of Alzheimer’s disease in mothers of adults with Down’s syndrome. The Lancet 1994; 344: 353-356.
4. Narchi H, Kulaylat N. High incidence of Down’s syndrome in infants of diabetic mothers. Arch Dis Child 1997; 77: 242-244.
5. Hassold T, Sherman S. Down syndrome: genetic recombination and the origin of the extra chromosome 21. Clin Genet 2000; 57: 95-100.
6. Barkai G, Arbuzova A, Berkenstadt M, Heifetz S, Cuckle H. Frequency of Down's syndrome and neural-tube defects in the same family. The Lancet 2003; 361: 1331-1335.
7. Gaulden ME Maternal age effect: the enigma of Down syndrome and other trisomic conditions. Mutat Res 1992; 296(1-2): 69-88.
8. Shapiro BL. The Down syndrome critical region. J Neural Transm (Suppl) 1999; 57: 41-60.
9. Arbuzova S. About the role of the mitochondrial DNA in the etiology of the regular trisomy 21. Cytol Genet 1995; 29(3): 77-80 (in Russian).
10. Arbuzova S. Free radicals in aetiology and pathogenesis of Down’s syndrome. Cytol Genet 1996; 30(2): 25-34 (in Russian).
11. Schon EA, Kim SH, Ferreira JC, Magalhaes P, Grace M, Warburton D, et al. Chromosomal non-disjunction in human oocytes: is there a mitochondrial connection? Hum Reprod 2000; 15(Suppl 2):160-172.
12. Arbuzova S. Why it is necessary to study the role of the mitochondrial genome in trisomy 21 pathogenesis? Down’s Syndrome: Res Pract 1998: 5(3): 26-29.
13. Schar P, Herrman G, Daly G, Lindahl T. A newly identified DNA ligase of Saccharomyces cerevisiae involved in RAD52-independent repair of DNA double-strand breaks. Genes Dev 1997; 11(15):1912-1924.
14. Strick TR, Croquette V, Bensimon D. Single-molecule analysis of DNA uncoiling by a type II topoisomerase. Nature 2000; 404: 901-904.
15. Beerman F, Hummler E, Franke U, Hansmann I. Maternal modulation of the inheritable meiosis I error Dipl I in mouse oocytes is associated with the type of mitochondrial DNA. Hum Genet 1988; 79(4): 338-340.
16. Keefe DL, Niven-Fairchild T, Powell S, Buradagunta S. Mitochondrial deoxyribonucleic acid deletions in oocytes and reproductive aging in women. Fertil Steril 1995; 64(3): 577-583.
17. Marchington DR, Scott Brown MS, Lamb VK, van Golde RJ, Kremer JA, Tuerlings JH, et al. No evidence for paternal mtDNA transmission to offspring or extra-embryonic tissues after ICSI. Mol Hum Reprod 2002; 8:1046-1049.
18. Wallace DC. Mitochondrial DNA mutations in diseases of energy metabolism. J Bioenerg Biomembrn 1994; 26: 241-250.
19. Pangalos CG, Conover Talbot C, Lewis JG, Adelsberger PA, Petersen MB, Serre J-L, Rethore M-O, de Blois M-C, Parent P, Schinzel AA, Binkert F, Boue J, Corbin E, Croquette MF, Gilgenkrantz S, de Grouchy J, Bertheas MF, Prieur M, Raoul O, Serville F, Siffroi JP, Thepot F, Lejeune J, Antonarakis SE. DNA polymorphism analysis in families with recurrence of free trisomy 21. Am J Hum Genet 1992; 51: 1015-1027.
20. Stinissen P, Van Roy B, Van Camp G, Backhovens H, Partoens P, Wehnert A, Verniers H, Dumon J, Vandenberghe A, Van Broeckhoven C. Study of the origin of non disjunction in a family with two cases of Down syndrome using cytogenetic and molecular polymorphisms. Am J Med Genet (Suppl) 1990; 7(Suppl): 133-136.
21. Arbuzova S, Hutchin T, Cuckle H. New mtDNA mutations in Down’s syndrome. DSNews 2000; 7(2): 27.
22. Busciglio J, Pelsman A, Wong C, Pigina G, Yuan M, Mori H, Yanker BA. Altered metabolism of the amyloid precursor protein is associated with mitochondrial dysfunction in Down’s syndrome. Neuron 2002; 33: 677-688.
23. Oikawa H, Tun Z, Young D, Ozawa H, Yamazaki K, Tanaka E, et al. The specific mitochondrial DNA polymorphism found in Klinefelter's syndrome. Biochem Biophys Res Commun 2002; 297: 341-345.
24. Parke JC, Grass FS, Pixley R, Deal J. Trisomy 21 mosaicism in two successive generations in a family. J Med Genet 1980; 17: 48-49.
25. Werner W, Herrmann FH, John B. Cytogenetic studies of a family with trisomy 21 mosaicism in two successive generations as the cause of Down’s syndrome. Hum Genet 1982; 60: 202-204.
26. Uchida IA, Freeman VC. Trisomy 21 Down syndrome. Parental mosaicism. Hum Genet 1985; 70(3): 246-248.
27. Munne S, Cohen J. Chromosome abnormalities in human embryos. Hum.Reprod. 1998; 4(6): 842-855.
28 Arbuzova S, Hutchin T, Cuckle H. Mitochondrial dysfunction and Down's syndrome. BioEssays 2002; 24: 681-684.
29. De La Torre R, Casado A, Lopez-Fernandez E, Carrascosa D, Ramires V, Saez J Overexpression of copper-zinc superoxide-dismutase in trisomy 21. Experientia 1996; 52(9): 871-873.
30. Korenberg JR, Kawashima H, Pulst SM, Ikeuchi T, Ogasawara N, Yamamoto K, Schonberg SA, West R, Allen L, Magenis E, et al. Molecular definition of a region of chromosome 21 that causes features of the Down syndrome phenotype. Am J Hum Genet 1990; 47(2): 236-246.
31. Feaster WW, Kwok LW, Epstein CJ. Dosage effects for the superoxide dismutase-1 in nucleated cells aneuploid for chromosome 21. Am J Hum Genet 1977; 29: 563-570.
32. Anneren KG, Epstein CJ. Lipid peroxidation and superoxide dismutase-1 and glutathione peroxidase activities in trisomy 16 fetal mice and human trisomy 21 fibroblasts. Pediatr Res 1987; 21(1): 88-92.
33. Jeziorowska A, Jakubowski L, Lach J, Kaluzewski B. Regular trisomy 21 not accompanied by increased copper-zinc superoxide-dismutase (SOD-1) activity. Clin Genet 1988; 33(1): 11-19.
34. Teksen F, Sayli BS, Aydin A, Sayal A, Isimer A Antioxidative metabolism in Down syndrome. Biol Trace Elem Res 1998; 63(2): 123-127.
